HIV PREVENTION FOR PEOPLE WITH DISABILITIES
ID: 356248Type: Posted
Overview

Buyer

U.S. Mission to Namibia (DOS-NAM)

Award Range

$3K - $16K

Eligible Applicants

Individuals

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Mandatory

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356248

Additional Information

https://na.usembassy.gov/education-culture/grant-programs/
Timeline
    Description

    The U.S. Mission to Namibia is offering a federal grant opportunity titled "HIV Prevention for People with Disabilities," aimed at supporting initiatives that enhance access to HIV prevention, testing, and treatment services for individuals with disabilities. Proposals should creatively address at least two key areas, including HIV prevention activities, community-based interventions, and campaigns to engage persons with disabilities in meaningful ways. This grant is particularly significant as it seeks to address the unique challenges faced by this demographic in accessing essential health services. Interested applicants can apply for funding amounts ranging from $2,800 to $16,000, with a total of two awards expected. The application deadline is September 16, 2024, and inquiries can be directed to Grants Officer Representative Albertina Kisting at KistingA@state.gov. For more information, please visit the U.S. Embassy's grant programs webpage.

    Point(s) of Contact
    KistingA@state.gov
    Files
    No associated files provided.
    Similar Opportunities
    Systems Strengthening for Better HIV/TB Patient Outcomes
    South Africa USAID-Pretoria
    The South Africa USAID-Pretoria is offering a federal grant opportunity titled "Systems Strengthening for Better HIV/TB Patient Outcomes," aimed at enhancing South African Government systems to improve patient outcomes and prevent HIV through comprehensive clinic-based services. Eligible applicants include local South African non-governmental organizations (NGOs) and for-profit organizations that meet specific criteria, with a focus on addressing all three objectives outlined in the Request for Application (RFA) for optimal evaluation. The program has an estimated total funding of $425 million, with individual awards ranging from $10 million to $150 million, and is expected to result in approximately eight awards. Interested organizations should submit their concept papers and full applications as per the guidelines provided, with inquiries directed to Beatrice Lumande at Applications4@usaid.gov or by phone at +27 12 452 2377.
    Microbicides Research, Development, and Introduction
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    Department of Defense HIV/AIDS Prevention Program
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a federal grant opportunity titled the Department of Defense HIV/AIDS Prevention Program (DHAPP). This program aims to save lives and prevent HIV infections by supporting the development of interventions and programs within military health systems, particularly in foreign countries, to achieve HIV/AIDS epidemic control. The DHAPP focuses on enhancing military capacity for ownership and behavioral change, aligning with national strategies, and ensuring sustainable HIV prevention and treatment services. Interested applicants can reach out to Ebony Simmons at ebony.s.simmons.civ@health.mil or by phone at 301-619-2105 for further information. The application deadline is September 18, 2027, with an expected seven awards to be made under this cooperative agreement, which does not require cost sharing or matching.
    Addressing Stigma to End the HIV Epidemic in the U.S.
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a funding opportunity titled "Addressing Stigma to End the HIV Epidemic in the U.S." aimed at supporting an organization that will implement, train, and evaluate anti-stigma interventions to enhance access to HIV care for underserved populations. The selected recipient will manage approximately 20 demonstration sites, facilitate national training, and develop a robust evaluation framework to assess the impact of these interventions over a four-year performance period, with a total funding amount of $25.25 million. This initiative is crucial for improving health outcomes by reducing stigma within healthcare systems, thereby increasing the availability of high-quality care, treatment, and prevention services for individuals affected by HIV. Interested applicants, including public and private nonprofits, state and local governments, and educational institutions, must submit their proposals by March 18, 2025, with the funded program expected to commence on September 1, 2025. For further inquiries, contact LaQuanta Smalley at SPNS@hrsa.gov.
    HIV/AIDS Orphans and Vulnerable Children and Adolescent Girls and Young Women Follow On Activity
    South Sudan (USAID)-Juba
    USAID South Sudan is forecasting a federal grant opportunity titled "HIV/AIDS Orphans and Vulnerable Children and Adolescent Girls and Young Women Follow On Activity," aimed at enhancing the resilience of high-risk children, youth, and their caregivers in South Sudan. The program's objectives include preventing new HIV infections, improving care retention and treatment adherence for those living with HIV, and reducing violence against vulnerable populations, particularly adolescent girls and young women. This initiative is critical for addressing health disparities and improving the overall well-being of affected communities in high-burden areas. Interested applicants must submit their proposals electronically by August 1, 2022, with an estimated award date of October 1, 2022. For further inquiries, contact Michael P. Loro at mloro@usaid.gov or by phone at 202-216-6279.
    Community Led Monitoring Intervention
    U.S. Mission to Mozambique
    The U.S. Mission to Mozambique is forecasting a funding opportunity titled "Community Led Monitoring Intervention" under the President's Emergency Plan for AIDS Relief (PEPFAR) Community Grants Program. This grant aims to support nonprofit national community organizations in Mozambique that focus on developing Community-Led Monitoring activities to enhance HIV prevention, care, and treatment services. The program is critical for addressing barriers to accessing HIV services and improving patient retention in care, with a total estimated funding of $500,000 available for approximately 20 awards, each ranging from $20,000 to $30,000. Interested organizations must submit their proposals by June 28, 2020, and can direct inquiries to Albertina M. Cossa at the PEPFAR Coordination Office via email at cossaam@state.gov.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Children, Adolescents & Families in the HIV Epidemic in the North West Province
    South Africa USAID-Pretoria
    The South Africa USAID-Pretoria is forecasting a cooperative agreement opportunity titled "Children, Adolescents & Families in the HIV Epidemic in the North West Province." This initiative aims to enhance the health and well-being of children and adolescents affected by HIV through comprehensive service delivery and strengthening local social service systems. The program is crucial for addressing the needs of vulnerable populations in alignment with the UNAIDS 95-95-95 goals for HIV treatment and care. Interested local entities are encouraged to provide feedback on the draft Notice of Funding Opportunity by April 6, 2023, with anticipated funding of up to $20 million. For further inquiries, contact Nompumelelo Mangqalaza at pretoriaapplications@usaid.gov or call 0124522000.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to HIV/AIDS within the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative encourages applications that address high-priority research areas identified by the NIH Office of AIDS Research, particularly focusing on the intersections of HIV/AIDS with hearing, communication, and associated disorders. Grants of up to $499,999 in direct costs are available for projects lasting up to five years, with no cost-sharing or matching requirements. Interested applicants, including educational institutions and community organizations, must adhere to NIH guidelines and submit their proposals through Grants.gov by the closing date of January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances" under the R34 planning grant mechanism. This initiative aims to encourage formative research and the development of innovative interventions that target HIV prevention and care, particularly for populations that engage in substance use, addressing critical gaps in HIV care and prevention. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofit entities, and tribal governments, with grants available for up to $450,000 over three years. The application cycle begins on April 7, 2025, with subsequent due dates throughout the year, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.